Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal SPG Blockade for Headaches Following aSAH
NCT07116408Phase 4Recruiting
- Sponsor
- Wright State University
- Start
- May 2024
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lidocaine 10% oropharyngeal spray in Headache, sponsored by Wright State University. Primary endpoint: Headache severity at 6 months. Started May 2024; status: recruiting.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
Headache
Beyond the preview
Go deeper on NCT07116408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07116408.